Mar 19, 2018 12:02 pm UTC| Business
Primary, secondary, and exploratory endpoints of Phase 2 trial met during 8-week treatment periodAfter treatment completed, greater improvement vs. placebo observed in 3-month post-treatment follow-up evaluationIf...
Mar 19, 2018 12:02 pm UTC| Business
DURHAM, N.C., March 19, 2018 -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA), a pharmaceutical company focused on acquiring, developing, and commercializing drug candidates for rare diseases where there is a high unmet...
Mar 19, 2018 12:02 pm UTC| Business
DOWNERS GROVE, Ill., March 19, 2018 -- FTD Companies, Inc. (Nasdaq:FTD) (“FTD” or the “Company”), a premier floral and gifting company, today announced that it will delay the release of its fourth quarter and full-year...
Mar 19, 2018 12:02 pm UTC| Business
NEW YORK, March 19, 2018 -- BeyondSpring Inc. (NASDAQ:BYSI), a global, clinical-stage biopharmaceutical company focused on the development of transformative cancer therapies, today announced that the Company has...
Mar 19, 2018 12:02 pm UTC| Business
PHOENIX, March 19, 2018 -- INSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today released the following...
Depomed Announces New Corporate Headquarters
Mar 19, 2018 12:02 pm UTC| Business
NEWARK, Calif., March 19, 2018 -- Depomed, Inc. (NASDAQ:DEPO) today announced it has signed a lease for its new corporate headquarters at 100 South Saunders Road in Lake Forest, Illinois, a northern Chicago suburb. The...
Vitality Biopharma CEO Robert Brooke Provides Shareholder Letter
Mar 19, 2018 12:02 pm UTC| Business
LOS ANGELES, March 19, 2018 -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of...